- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Dihydrouracil Dehydrogenase (NADP)
Total 1131 results
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...CompletedRenal Cell CarcinomaChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityZai Lab (Shanghai) Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedPlatinum-resistant Recurrent Clear Cell Ovarian CancerChina
-
Spanish Oncology Genito-Urinary GroupAstraZeneca; Apices Soluciones S.L.CompletedProstate Cancer MetastaticSpain
-
AstraZenecaCompletedBreast Cancer | Ovarian CancerIndia
-
Samsung Medical CenterCompleted
-
MedSIRAstraZeneca; ExperiorCompleted
-
Yale UniversityWithdrawnSquamous Cell Carcinoma of the Head and Neck
-
AbbVieCompletedOncology | High Grade Serous Ovarian Cancer | BRCA Mutated | BRCA Mutated Breast Cancer
-
NeoTX Therapeutics Ltd.AstraZenecaActive, not recruitingMelanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Pancreatic Adenocarcinoma | Ovarian Cancer | NSCLC | Prostate Cancer | Mesothelioma | Bladder Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Colorectal Cancer Metastatic | Head and Neck Squamous Cell Carcinoma | Urothelial Cancer | Cervical Squamous... and other conditionsIsrael
-
Sunnybrook Health Sciences CentreGlaxoSmithKlineRecruitingOvarian Cancer | Stage IV Ovarian Cancer | High Grade Ovarian Serous Adenocarcinoma | Stage III Ovarian CancerCanada
-
Zhejiang Cancer HospitalSun Yat-sen University; Fujian Cancer Hospital; Hunan Cancer Hospital; Zhejiang... and other collaboratorsNot yet recruitingTriple Negative Breast Cancer | Homologous Recombination Deficiency
-
SOLTI Breast Cancer Research GroupRecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | HER2-negative Breast CancerSpain
-
Ling-Ying WuNot yet recruiting
-
Yonsei UniversityNot yet recruitingTNBC - Triple-Negative Breast CancerKorea, Republic of
-
Tongji HospitalSun Yat-sen University; Qilu Hospital of Shandong University; Hubei Cancer Hospital and other collaboratorsRecruiting
-
Laval UniversityCanadian Institutes of Health Research (CIHR); AstraZenecaRecruiting
-
Dana-Farber Cancer InstituteAstraZenecaWithdrawnUveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Recurrent Metastatic MelanomaUnited States
-
AstraZenecaActive, not recruitingOvary CancerFrance, United Kingdom
-
PfizerCompleted
-
Abramson Cancer Center at Penn MedicineTerminatedPancreatic CancerUnited States
-
Memorial Sloan Kettering Cancer CenterClovis Oncology, Inc.Active, not recruiting
-
University of Texas Southwestern Medical CenterCompletedBreast Cancer | Ovarian CancerUnited States
-
Hellenic Cooperative Oncology GroupActive, not recruitingOvarian CancerGreece
-
Spanish Breast Cancer Research GroupAstraZenecaCompleted
-
AstraZenecaCompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Canada
-
Maastricht UniversityTerminated
-
University Medical Center GroningenAbbVie; Dutch Cancer SocietyWithdrawn
-
AstraZenecaCompleted
-
Tianjin Medical University Cancer Institute and...RecruitingExtensive-stage Small Cell Lung CancerChina
-
Erasmus Medical CenterRecruitingNeuroendocrine Tumors | Peptide Receptor Radionuclide TherapyNetherlands
-
Ruijin HospitalNot yet recruiting
-
Sichuan Cancer Hospital and Research InstituteNot yet recruiting
-
Wuhan UniversityNot yet recruitingRecurrent Small Cell Lung Cancer
-
National University Hospital, SingaporeRecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast CancersSingapore
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, China, Spain, Japan, United Kingdom
-
AstraZenecaMerck Sharp & Dohme LLC; NRG Oncology; Breast International Group; Myriad Genetic... and other collaboratorsActive, not recruitingBreast CancerUnited States, Austria, Italy, Spain, Sweden, United Kingdom, Belgium, Poland, France, Switzerland, Canada, Germany, Korea, Republic of, Netherlands, Japan, China, Taiwan, Australia, Argentina, Israel, Hungary, Portugal, Iceland, Puerto...
-
PfizerCompletedBreast CancerUnited States
-
The University of Hong KongCompletedOvarian CancerHong Kong
-
University College, LondonAstraZeneca; Cancer Research UKActive, not recruitingHead and Neck CancerUnited Kingdom
-
Dantari, Inc.CompletedHER2-negative Metastatic Breast CancerUnited States
-
Janssen Research & Development, LLCActive, not recruitingProstatic NeoplasmsUnited States, Australia, France, United Kingdom, Belgium, Taiwan, Spain, Israel, Netherlands, Sweden, Korea, Republic of, Canada, Russian Federation, Brazil, Denmark
-
AstraZenecaParexel; Covance; Iqvia Pty Ltd; Theradex; Myriad Genetics, Inc.CompletedNon-Germline BRCA Mutated Ovarian CancerItaly, Spain, Sweden, Canada, Czechia, Poland, United Kingdom, Israel, Austria, Belgium, Switzerland, Netherlands, Bulgaria, Finland, Norway, Denmark, Slovenia, Portugal
-
PfizerMedivation, Inc.CompletedCancerUnited States, Canada, United Kingdom, France, Poland, Hungary, Germany, Moldova, Republic of, Russian Federation
-
TakedaCompletedAdvanced Solid TumorsJapan
-
AstraZenecaCompletedLymphoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Malignant Solid TumorsUnited States, Canada
-
Istituto Scientifico Romagnolo per lo Studio e...UnknownNeoplasms, Germ Cell and EmbryonalItaly
-
Peking University Cancer Hospital & InstituteUnknownPancreatic Cancer | Gastric Adenocarcinoma | Cholangiocarcinoma | HER2-negative Breast CancerChina
-
Hunan Cancer HospitalUnknown
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan
-
Istituti Ospitalieri di CremonaUnknownBreast Cancer | Triple Negative Breast Cancer